FIM
BNTX icon

Freedom Investment Management’s BioNTech BNTX Stock Holding History

Freedom Investment Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,936
Closed -$221K – 747
2024
Q4 		$221K Sell
1,936
-110
-5% -$12.6K 0.02% 695
2024
Q3 		$243K Buy
+2,046
New +$188K 0.02% 658
2022
Q1 		– Sell
-1,123
Closed -$290K – 798
2021
Q4 		$290K Sell
1,123
-13
-1% -$3.56K 0.02% 685
2021
Q3 		$310K Sell
1,136
-20
-2% -$6.36K 0.02% 624
2021
Q2 		$259K Buy
+1,156
New +$218K 0.02% 740

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Freedom Investment Management's BNTX Position: Q1 2025 in Review

Freedom Investment Management sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 1,936 shares — an estimated $221K sold.

Freedom Investment Management first reported a position in BNTX in Q2 2021 and held it in 5 quarters. The position peaked at $310K in Q3 2021. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • Freedom Investment Management reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
  • Freedom Investment Management sold 1,936 BioNTech shares in Q1 2025, an estimated $221K.
  • Freedom Investment Management first reported a position in BioNTech in Q2 2021 and held it in 5 quarters.
  • Freedom Investment Management's BioNTech position peaked at $310K in Q3 2021.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Freedom Investment Management's 13F filing for Q1 2025, filed 14 May 2025.